Grant R. Bowman

In this project, Grant's primary role will be to advise Nikolai Mushnikov, lead scientist and co-founder of the small business interest AsimicA, and a graduate student who will contribute to the project on the university side of the project. Nikolai and Grant have been working together productively for the past seven years. He began his PhD thesis studies in Grant's laboratory in 2012 and will graduate in 2019. In addition to mentoring Nikolai, he has graduated two other PhD students since founding the lab in 2012 and is in the process of training three others. Together, these experiences have provided Grant with expertise in project management, which he will apply in guiding AsimicA towards achieving its scientific goals.

AsimicA, is founded on a core set of genetic technology that allows them to establish and control asymmetric cell division and cell differentiation in bacterial cells. This technology is protected by a provisional patent and can expect further protection from a non-provisional patent that is currently under review at the United States Patent Office. Thanks to patent protection, AsimicA is the only entity that can legally pursue this approach towards increasing bioreactor yields, making the company the sole choice for embarking this scientific and commercial endeavor.

More importantly, NikolaI Mushnikov and Grant are the primary inventors of AsimicA technology. Because they have extensive hands-on technical experience with the invention, they are better suited to the task of making it a scientific success than anybody else. Furthermore, because they have worked hard together to transform their concepts from white-board sketches to a registered company, they are strongly driven to achieve commercial success.